Sort
46,585 grants matching “heart failure”
Treatment-Related Cardiotoxicity in Children with Relapsed Acute Myeloid Leukemia - Natural History, Occurrence and Implications
$746,751Kelly Diringer Getz · University Of Pennsylvania · R01 · FY2023 · HL
Defining Genetic Architecture and Pathways of DCM
$746,700Jonathan G Seidman · Harvard Medical School · R01 · FY2021 · HL
Depression and Heart Failure Disease Progression
$746,665Andrew Sherwood · Duke University · R01 · FY2014 · HL
Advanced Heart Failure: Epidemiology and Outcomes
$746,610Shannon Marie Dunlay · Mayo Clinic Rochester · R01 · FY2020 · HL
Developing and applying information extraction resources and technology to create
$746,561Lawrence E Hunter · University Of Colorado Denver · R01 · FY2014 · LM
CV Benefits and Safety of Glucose-Lowering Therapies in Adults with Diabetes
$746,462Patrick J O'Connor · Healthpartners Institute · R01 · FY2015 · HL
Systems Pharmacology Model of Cardiac Hypertrophy
$746,423Jeffrey J. Saucerman · University Of Virginia · R01 · FY2024 · HL
Development of a Miniaturized, Pediatric Continuous-Flow Total Artificial Heart with a Single Moving Part
$746,410Kiyotaka Fukamachi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · HL
The molecular and cellular mechanisms of the STAT3 mutation-mediated pulmonary disorder in Autosomal Dominant Hyper IgE Syndrome (AD-HIES)
$746,333Richard C Boucher · Univ Of North Carolina Chapel Hill · U01 · FY2024 · HL
Mechanisms involved in male-female differences in cardioprotection
$746,278Elizabeth Murphy · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Active Bottle for Home Care of Dysphagic Infants - Phase II
$746,273Gordon Hirschman · Infoscitex Corporation · R44 · FY2009 · HD
Predictive and systems modeling of exosome cargo
$746,238Michael E Davis · Emory University · R01 · FY2021 · HL
Genomics of Post-Operative Atrial Fibrillation After Cardiac Surgery
$746,205Jochen Daniel Muehlschlegel · Johns Hopkins University · R01 · FY2024 · HL
Defining the lymphatic basis of protein losing enteropathy after Fontan palliation or inflammatory gut disease
$746,178Gwendalyn J Randolph · Washington University · DP1 · FY2023 · DK
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy
$746,147Scott Matthew Ebert · Emmyon, Inc. · R44 · FY2018 · AG
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy
$746,147Scott Matthew Ebert · Emmyon, Inc. · R44 · FY2019 · AG
HLS- Cyclic CAR peptide: a targeted therapy for pulmonary hypertension
$746,137Paul B Yu · Vascular Biosciences · R42 · FY2019 · HL
A Systems Biology Approach to Study Cardiac Arrhythmias: iPS Cells and In Silico Modeling
$746,125Joseph C Wu · Stanford University · R01 · FY2017 · HL
Proteasomal Degradation of XPB as a Novel Mechanism for Treating Inflammation
$746,089Jason Elinoff · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Uncovering early signals of hereditary TTR amyloidosis in minority populations at high genetic risk
$746,054Amy R. Kontorovich · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · HL
BEST-VIVA Registry (vCLI)
$745,998Manesh R Patel · Duke University · R01 · FY2021 · HL
The Road to Destination Therapy: Developing a Durable Ambulatory Mechanical Cardiopulmonary Support for Pulmonary Hypertension
$745,932Matthew Dominic Bacchetta · Vanderbilt University Medical Center · R01 · FY2025 · HL
Development of a Universal Bi-ventricular Replacement System for the Failing Heart
$745,926Joshua P Cysyk · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · HL
Implementing Remote Patient Monitoring to Improve Hypertension Control in a Primary Care Network
$745,923Ian Matthew Kronish · Columbia University Health Sciences · R01 · FY2021 · HL
Innate/ SIV DNA vaccine induced immunity in the protected macaque mucosa
$745,851Michael A Murphey-Corb · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · AI